0 May 2013 10:24
Biosensors International Group, Ltd. has announced CE Mark
approval for BioMatrix NeoFlex, the latest addition to the BioMatrix
family of drug-eluting stents. BioMatrix NeoFlex features a new advanced
stent delivery system, improving pushability, trackability and
crossability.
It also has a lower lesion entry profile than its
predecessor. BioMatrix NeoFlex retains the same unique combination of
abluminal biodegradable polymer coating, proprietary limus drug Biolimus
A9 and flexible platform which has made the BioMatrix stent family an
increasingly popular choice of DES in the global markets where it is
available...
No comments:
Post a Comment